Citigroup Inc Medicinova Inc Put Options Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MNOV
# of Institutions
27Shares Held
5.15MCall Options Held
28.5KPut Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.44 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$903,4250.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA687KShares$892,5500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA526KShares$683,6590.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA250KShares$325,1490.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $63.8M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...